BASF Expands Portfolio With ZeroPCF Superabsorbent Polymer

11.02.25 16:24 Uhr

Werte in diesem Artikel
Aktien

46,85 EUR -0,45 EUR -0,94%

Indizes

PKT PKT

1.878,4 PKT 11,1 PKT 0,60%

22.037,8 PKT 126,1 PKT 0,58%

8.466,3 PKT 48,4 PKT 0,58%

497,8 PKT -1,2 PKT -0,24%

196,1 PKT -0,5 PKT -0,24%

550,0 PKT 2,7 PKT 0,49%

5.390,9 PKT 32,6 PKT 0,61%

6.193,8 PKT -6,9 PKT -0,11%

11.439,4 PKT 49,1 PKT 0,43%

22.109,5 PKT 161,5 PKT 0,74%

22.053,7 PKT 128,1 PKT 0,58%

8.517,1 PKT 45,8 PKT 0,54%

4.681,7 PKT 9,2 PKT 0,20%

22.097,0 PKT 147,0 PKT 0,67%

BASF SE BASFY introduces the first polyacrylate-based superabsorbent polymer (SAP), HySorb B 6610 ZeroPCF, with a carbon footprint of zero. The SAP is marketed with a product carbon footprint (PCF) of zero for the hygiene industry. The zero PCF polymer expands BASFY’s sustainable portfolio. This has been achieved by utilizing renewable energy in addition to the established biomass balance approach (BMB) in the production process at the Antwerp Verbund site. This ISCC PLUS-certified product offers a solution to help customers in the hygiene industry in Europe, Middle East and Africa to achieve their own sustainability targets by enabling them to reduce their scope 3 footprint. HySorb B 6610 ZeroPCF is a drop-in solution that will not require adaptation of a diaper production line or compromise on product quality and performance, much like BASFY’s existing HySorb B 6610 BMB that is also being offered to support customers’ sustainability transformation.BASFY stock has gained 1.2% in the past year against the 3.4% dip in the industry.Image Source: Zacks Investment ResearchBASFY’s Zacks Rank and Key Picks    BASFY currently carries a Zacks Rank #4 (Sell).Some better-ranked stocks in the Basic Materials space are Ingevity Corporation NGVT, Carpenter Technology Corporation CRS and Methanex Corp. MEOH. While NGVT sports a Zacks Rank #1 (Strong Buy), CRS and MEOH carry a Zacks Rank #2 (Buy) each at present. You can see the complete list of today’s Zacks #1 Rank stocks here.The Zacks Consensus Estimate for Ingevity’s current-year earnings is pegged at $2.75 per share. NGVT beat the Zacks Consensus Estimate in three of the trailing four quarters and missed once, with the average earnings surprise being 95.4%.The Zacks Consensus Estimate for Carpenter Technology’s current fiscal-year earnings is pegged at $6.83 per share. CRS beat the Zacks Consensus Estimate in each of the trailing four quarters, with the average earnings surprise being 15.7%. Its shares have soared 199.3% in the past year.The Zacks Consensus Estimate for Methanex’s current-year earnings is pegged at $4.2 per share. MEOH surpassed the Zacks Consensus Estimate in each of the trailing four quarters, with an average earnings surprise of 85.2%. The stock has gained 6.9% in the past year.Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 256 positions with double- and triple-digit gains in 2024 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report BASF SE (BASFY): Free Stock Analysis Report Carpenter Technology Corporation (CRS): Free Stock Analysis Report Methanex Corporation (MEOH): Free Stock Analysis Report Ingevity Corporation (NGVT): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf BASF

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf BASF

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu BASF

Wer­bung

Analysen zu BASF

DatumRatingAnalyst
10.02.2025BASF OutperformBernstein Research
07.02.2025BASF NeutralJP Morgan Chase & Co.
05.02.2025BASF NeutralJP Morgan Chase & Co.
28.01.2025BASF NeutralJP Morgan Chase & Co.
27.01.2025BASF KaufenDZ BANK
DatumRatingAnalyst
10.02.2025BASF OutperformBernstein Research
27.01.2025BASF KaufenDZ BANK
27.01.2025BASF BuyDeutsche Bank AG
27.01.2025BASF BuyBaader Bank
27.01.2025BASF BuyGoldman Sachs Group Inc.
DatumRatingAnalyst
07.02.2025BASF NeutralJP Morgan Chase & Co.
05.02.2025BASF NeutralJP Morgan Chase & Co.
28.01.2025BASF NeutralJP Morgan Chase & Co.
27.01.2025BASF NeutralUBS AG
20.01.2025BASF NeutralJP Morgan Chase & Co.
DatumRatingAnalyst
26.07.2024BASF UnderperformJefferies & Company Inc.
27.06.2024BASF UnderperformJefferies & Company Inc.
26.04.2024BASF UnderperformJefferies & Company Inc.
25.04.2024BASF UnderperformJefferies & Company Inc.
25.03.2024BASF UnderperformJefferies & Company Inc.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für BASF nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"